19.70
0.00%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Mevis Medical Solutions
Its shares trade on XETRA under the ticker M3V.DE. It has been listed since 16 November 2007. In the fiscal year to 30 September 2025, it reported revenue of €16.1m and net income of €3.2m. At that date it held total assets of €25.9m and shareholders' equity of €17.8m.
MeVis Medical Solutions AG engages in the development of software for analyzing and evaluation image data for manufacturers of medical devices and providers of medical information technology platforms. The company is headquartered in Bremen, Bremen. The company went IPO on 2007-11-16. The firm develops medical application software for industrial customers including turnkey applications, and also research laboratories. In addition to that, the Company operates an online academy and trains professionals, such as radiologists, in working with its products. The firm's software applications support various applicable imaging modalities, especially magnetic resonance tomography (MRT) and digital mammography, but also computer tomography (CT), tomosynthesis and digital sonography based on ultrasonics.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 16 Nov 2007
- Employees
- 95
- Website
- mevis.de ↗
Leadership
Pay as last reported
- Ms. Kimberley HoneysettChairman of the Supervisory Board, since 2017
- Mr. Marcus KirchhoffChairman of the Executive Board, Chief Executive Officer€307,262
- Mr. Shubham MaheshwariDeputy Chairman of the Supervisory Board, since 2021
- Mr. Sunny SanyalMember of the Supervisory Board, since 2020
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Mevis Medical Solutions AG has a strong reputation in the medical imaging industry, offering high-quality products and services.
- The company possesses advanced technological capabilities and expertise, allowing them to deliver innovative solutions to their customers.
- Mevis Medical Solutions AG has established a global presence, with a wide customer base and partnerships with leading healthcare organizations.
Weaknesses
- One potential weakness of Mevis Medical Solutions AG is its dependency on external suppliers for key components and materials, which can introduce supply chain risks.
- The company may face challenges in adapting to rapidly changing technology trends and market demands, requiring continuous investment in research and development.
- In some markets, Mevis Medical Solutions AG may face strong competition from established players that have larger market shares and resources.
Opportunities
- The increasing global demand for advanced medical imaging solutions presents significant growth opportunities for Mevis Medical Solutions AG.
- The company can explore strategic partnerships or acquisitions to expand its product portfolio and enter new markets, enhancing its competitive advantage.
- The ongoing digital transformation in the healthcare industry provides an opportunity for Mevis Medical Solutions AG to develop and market new digital imaging solutions.
Threats
- New regulatory requirements and compliance standards in the healthcare industry can pose challenges to Mevis Medical Solutions AG, requiring ongoing investments to ensure compliance.
- Intense competition from both existing and emerging players in the medical imaging market may impact the market share and profitability of Mevis Medical Solutions AG.
- Economic uncertainties and fluctuations in currency exchange rates can influence the company's financial performance, particularly in international markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.